Avita Medical Submitted A Premarket Approval Supplement To The FDA For RECELL GO. The Supplement Follows The Original PMA Of Its RECELL Autologous Cell Harvesting Device And Subsequent PMA Supplements
Portfolio Pulse from Benzinga Newsdesk
Avita Medical has submitted a premarket approval supplement to the FDA for RECELL GO, following the original PMA of its RECELL Autologous Cell Harvesting Device and subsequent PMA supplements.
June 30, 2023 | 8:23 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avita Medical's submission of a premarket approval supplement for RECELL GO to the FDA could potentially impact the company's stock.
The submission of a premarket approval supplement to the FDA is a significant step for Avita Medical. If approved, it could potentially increase the company's market share and revenue, positively impacting its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100